Tsumura & Co
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo po… Read more
Market Cap & Net Worth: Tsumura & Co (TSUA)
Tsumura & Co (MU:TSUA) has a market capitalization of $1.85 Billion (€1.81 Billion) as of March 18, 2026. Listed on the MU stock exchange, this Germany-based company holds position #5658 globally and #592 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tsumura & Co's stock price €23.60 by its total outstanding shares 76508400 (76.51 Million).
Tsumura & Co Market Cap History: 2015 to 2025
Tsumura & Co's market capitalization history from 2015 to 2025. Data shows growth from $2.00 Billion to $1.85 Billion (1.31% CAGR).
Tsumura & Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tsumura & Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Tsumura & Co's market cap is 0.01 times its annual revenue
0.76x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.06x
Tsumura & Co's market cap is 0.06 times its annual earnings
4.49x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.18 Billion | $114.96 Billion | $12.49 Billion | 0.02x | 0.17x |
| 2018 | $1.87 Billion | $117.88 Billion | $14.50 Billion | 0.02x | 0.13x |
| 2019 | $2.03 Billion | $120.91 Billion | $14.59 Billion | 0.02x | 0.14x |
| 2020 | $1.85 Billion | $123.25 Billion | $13.77 Billion | 0.02x | 0.13x |
| 2021 | $1.85 Billion | $116.41 Billion | $15.33 Billion | 0.02x | 0.12x |
| 2022 | $1.85 Billion | $129.55 Billion | $18.84 Billion | 0.01x | 0.10x |
| 2023 | $1.85 Billion | $140.04 Billion | $16.48 Billion | 0.01x | 0.11x |
| 2024 | $1.85 Billion | $150.84 Billion | $16.71 Billion | 0.01x | 0.11x |
| 2025 | $1.85 Billion | $181.09 Billion | $32.43 Billion | 0.01x | 0.06x |
Competitor Companies of TSUA by Market Capitalization
Companies near Tsumura & Co in the global market cap rankings as of March 18, 2026.
Key companies related to Tsumura & Co by market ranking:
- Lavipharm S.A (AT:LAVI): Ranked #19144 globally with a market cap of $80.56 Million USD ( €78.48 Million EUR).
- Medicon Hellas S.A. (AT:MEDIC): Ranked #43543 globally with a market cap of $23.83K USD ( €23.21K EUR).
- Hillman Solutions Corp (NASDAQ:HLMN): Ranked #5649 globally with a market cap of $1.59 Billion USD.
- Tasly Pharmaceutical Group Co Ltd (SHG:600535): Ranked #5650 globally with a market cap of $1.58 Billion USD ( CN¥11.63 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #19144 | Lavipharm S.A | AT:LAVI | $80.56 Million | €1.23 |
| #43543 | Medicon Hellas S.A. | AT:MEDIC | $23.83K | €2.44 |
| #5649 | Hillman Solutions Corp | NASDAQ:HLMN | $1.59 Billion | $8.11 |
| #5650 | Tasly Pharmaceutical Group Co Ltd | SHG:600535 | $1.58 Billion | CN¥14.26 |
Tsumura & Co Historical Marketcap From 2015 to 2025
Between 2015 and today, Tsumura & Co's market cap moved from $2.00 Billion to $ 1.85 Billion, with a yearly change of 1.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €1.85 Billion | 0.00% |
| 2024 | €1.85 Billion | 0.00% |
| 2023 | €1.85 Billion | 0.00% |
| 2022 | €1.85 Billion | 0.00% |
| 2021 | €1.85 Billion | 0.00% |
| 2020 | €1.85 Billion | -8.53% |
| 2019 | €2.03 Billion | +8.45% |
| 2018 | €1.87 Billion | -14.15% |
| 2017 | €2.18 Billion | +6.89% |
| 2016 | €2.04 Billion | +1.87% |
| 2015 | €2.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tsumura & Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.85 Billion USD |
| MoneyControl | $1.85 Billion USD |
| MarketWatch | $1.85 Billion USD |
| marketcap.company | $1.85 Billion USD |
| Reuters | $1.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.